BLFS241220P15000
- 0.30
- 0.000.00%
BioLife Solutions Newsroom
Jefferies Maintains BioLife Solutions(BLFS.US) With Buy Rating, Maintains Target Price $31
Jefferies Initiates BioLife Solutions(BLFS.US) With Buy Rating, Announces Target Price $31
BioLife Solutions Is Maintained at Overweight by Keybanc
BioLife Solns Analyst Ratings
KeyBanc Maintains BioLife Solutions(BLFS.US) With Buy Rating, Raises Target Price to $33
Northland Securities Maintains BioLife Solutions(BLFS.US) With Buy Rating, Maintains Target Price $28
Analysts Offer Insights on Healthcare Companies: BioLife Solutions (BLFS) and Sinopharm Group Co (OtherSHTDF)
Maxim Group Maintains BioLife Solutions(BLFS.US) With Buy Rating, Maintains Target Price $30
H.C. Wainwright Maintains BioLife Solutions(BLFS.US) With Buy Rating, Cuts Target Price to $27
BioLife Solutions Is Maintained at Buy by HC Wainwright & Co.
BioLife Solns Analyst Ratings
BioLife Solutions: Strategic Refocus and Strong Q3 Performance Bolster Buy Rating With $27 Price Target
A Quick Look at Today's Ratings for BioLife Solutions(BLFS.US), With a Forecast Between $28 to $32
A Quick Look at Today's Ratings for BioLife Solutions(BLFS.US), With a Forecast Between $28 to $32
BioLife Solutions Is Maintained at Buy by Craig-Hallum
BioLife Solns Analyst Ratings
TD Cowen Maintains BioLife Solutions(BLFS.US) With Buy Rating, Raises Target Price to $31
BioLife Solutions: Strategic Refocus and Strong Financial Performance Justify Buy Rating
Craig-Hallum Maintains BioLife Solutions(BLFS.US) With Buy Rating
Lake Street Maintains BioLife Solutions(BLFS.US) With Buy Rating, Maintains Target Price $28